GSP Crop Science Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹2(0.63%)
Premium (ELP)
GSP Crop Science Limited's successfully completed its Initial Public Offering and commenced trading on Mar 24, 2026 at the NSE, BSE exchange. The company raised 1,25,00,000 Shares through this public offering, comprising 75,00,000 Shares in fresh capital and ₹160.00 Cr through the Offer for Sale mechanism.
The IPO was priced within the band of ₹304 to ₹320, with minimum application lots of 46 shares. The offering attracted significant investor interest during its subscription period from Mar 16, 2026 to Mar 18, 2026.
Share allotment was finalized on Mar 20, 2026, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
GSP Crop Science Limited, incorporated in 1985, is an agrochemical company engaged in the manufacturing of insecticides, herbicides, fungicides, and plant growth regulators that help farmers improve crop productivity and protect plants from pests, weeds, and diseases. The company develops, manufactures, and supplies a wide range of crop protection solutions in the form of formulations and technicals, serving both domestic and international B2B customers in the agrochemical industry. Over the years, it has built long-term relationships with clients, providing a diversified customer base in a dynamic market environment. As of September 30, 2024, the company had received 507 registrations for its agrochemical products and held 89 patents, with patented products contributing ₹1,441.11 million, or about 20.73% of revenue, during the six months ended September 30, 2024. GSP Crop Science also focuses on research and development to improve its formulations and technicals, supported by dedicated facilities at Kathwada and Odhav for testing, commercialization, and production of complex chemistries for the agrochemical industry.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Diversified Agrochemical Portfolio: Offers insecticides, herbicides, fungicides, and plant growth regulators across formulations and technicals, supported by 524 product registrations.
- Strong In-House R&D: Dedicated research facilities support innovation, new product development, and process improvements.
- Robust Manufacturing Infrastructure: Operates five manufacturing units with strong capacity for technicals, formulations, and intermediates.
- Regulatory Approval & Licensing Risk: Operations depend on statutory approvals and product registrations from authorities such as CIBRC. Any delay, failure to obtain, or non-renewal of these approvals may affect operations.
- Quality & Technical Compliance Risk: Products must meet strict quality and technical standards. Any failure in manufacturing processes, raw material quality, or compliance could lead to customer loss and reputational damage.
- Distribution Network Dependency Risk: The domestic formulations business relies heavily on a wide distributor network across India. Any disruption or ineffective management of this network may impact sales and growth.
- Bhavesh Vrajmohan Shah
- Tirth Kenal Shah
- Vilasben Vrajmohan Shah
- Falguni Kenal Shah
- Alpha Trust
- Kappa Trust
GSP Crop Science Limited
Link Intime India Private Limited